article thumbnail

AbbVie sucks

World of DTC Marketing

market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. Sales of Humira earned AbbVie $20.7

article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s position in the global pharmaceutical packaging and labelling market The authors highlighted that Europe led the worldwide market at 27 percent in 2022. The authors wrote that driving factors include increasing demand for branded drugs, over the counter medicines as well as specialty medicine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How pharma knowledge and marketing influences prescriptions written by doctors

eMediWrite

Knowledge marketing is a crucial method for influencing doctors’ prescription practises in the pharmaceutical business. E-detailing, or physical LBLs in which a medical representative uses an online platform, or print input respectively to detail a pharmaceutical product to a doctor.

Doctors 40
article thumbnail

KFA-115 by Novartis for Melanoma: Likelihood of Approval

Pharmaceutical Technology

Novartis overview Novartis is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products.

article thumbnail

Elite 2024 Disrupter Bryan Johnson of Veeva Systems

PM360

For example, Bryan’s leadership played a pivotal role in the design and development of Veeva Compass’ modern data products—Veeva Compass Prescriber and National—featuring prescriber -and national- level projections based on both prescription and medical claims. As rare diseases affect about 1 in 10 people in the U.S.,

Retail 52
article thumbnail

The Future of Medical Sales

MaBiCo

A pharmaceutical company with so many regulatory restrictions has very few options to attract clients (i.e. patients); and the most common of all is and will remain physicians’ recommendations and prescriptions. But in order to be successful, med reps need to evolve.

article thumbnail

Detailing to Pharmacies

MaBiCo

An increasing number of sales managers in Greece report to their companies incidents of pharmacists who “switch” doctors’ prescriptions and bypass their recommendations. In these cases the patients end up buying a competitive product recommended by the pharmacists instead of those recommended by the doctors. Detailing to Pharmacies.

Doctors 52